Full Length Research Paper
References
|
Abdul-Hay SO, Lane AL, Caulfield TR, Claussin C, Bertrand J, Masson A, Leissring MA. (2013). Optimization of Peptide Hydroxamate Inhibitors of Insulin-Degrading Enzyme Reveals Marked Substrate-Selectivity. J. Med. Chem. 56(6):2246-2255. |
|
|
Agha KA, Abo-Dya NE, Ibrahim TS, Abdel-Aal EH (2016). Efficient synthesis of N-acylbenzotriazoles using tosyl chloride: en route to suberoylanilide hydroxamic acid (SAHA). ARKIVOC 3:161-70. |
|
|
Amata O, Marino T, Russo N, Toscano M (2009). Human insulin-degrading enzyme working mechanism. J. Am. Chem. Soc. 131(41):14804-14811. |
|
|
Bray GA, Nielsen SJ, Popkin BM (2004). Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am. J. Clin. Nutr. 79(4):537-543. |
|
|
Butterfield WJ (1970). Insulin clearance in nondiabetic and diabetic subjects. Panminerva Med. 12(6):233-235. |
|
|
Deprez-Poulain R, Hennuyer N, Bosc D, Liang WG, Enée E, Marechal X, Verdelet T (2015). Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice. Nat. Commun. 6:1-6. |
|
|
Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI. (1999). Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidyl inositol 3-kinase activity. J. Clin. Invest. 103:253-259. |
|
|
Duckworth WC, Bennett RG, Hamel FG (1998). Insulin degradation: progress and potential. Endocr. Rev. 19(5):608-24. |
|
|
Hamel FG, Upward JL, Bennett RG (2003). In vitro inhibition of insulin-degrading enzyme by long-chain fatty acids and their coenzyme A thioesters. Endocrinology 144(6):2404-2408. |
|
|
Hulse RE, Ralat LA, Wei-Jen T. (2009). Structure, function, and regulation of insulin-degrading enzyme. Vitam. Horm. 80:635-648. |
|
|
Miriam ET (2015). IDF Atlas: About 415 Million Adults Worldwide Have Diabetes. Medscape. |
|
|
Iliya A, Mohammed B, Akuyam SA, Nok AJ, Bauchi ZM, Tanko M, Timbuak JA, Yusuf B (2016). Molecular mechanisms of insulin signaling. Sub-Saharan Afr. J. Med. 3:3-7. |
|
|
Junlan Z, Gangjian Q (2012). Adipocyte dysfunction and hypertension. Am. J. Cardiovasc. Dis. 2(2):143-149. |
|
|
Karamohamed S, Demissie S, Volcjak J, Liu C, Heard-Costa N, Liu J, Shoemaker CM, Panhuysen CI, Meigs JB, Wilson P, Atwood LD, Cupples LA, Herbert A. (2003). Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. Diabetes 52(6): 1562-1567. |
|
|
Kershaw EE, Flier JS (2004). Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89(6):2548-2556. |
|
|
Kim JK, Fillmore JJ, Sunshine MJ, Albrecht B, Higashimori T, Kim DW, Liu ZX, Soos TJ, Cline GW, O'Brien WR, Littman DR, Shulman GI. (2004). PKC-theta knockout mice are protected from fat-induced insulin resistance. J. Clin. Invest. 114(6):823-827. |
|
|
Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H. (2008). Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology 135(1):122-130. |
|
|
Leissring MA, Malito E, Hedouin S, Reinstatler L, Sahara T, Abdul-Hay SO, Choudhry S, Maharvi GM, Fauq AH, Huzarska M, May PS, Choi S, Logan TP, Turk BE, Cantley LC, Manolopoulou M, Tang WJ, Stein RL, Cuny GD, Selkoe DJ (2010). Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin. PLoS ONE 5(5): e10504. |
|
|
Li CZ, Zhang SH, Shu CD, Ren W (2002). [Relationship between insulin-degrading enzyme activity and insulin sensitivity in cell model of insulin-resistance]. Di 1 jun yi da xue xue bao= Academic journal of the first medical college of PLA 22(2):151-154. |
|
|
Maestro B, Campión J, Dávila N, Calle C (2000). Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr. J. 47(4):383-91. |
|
|
Maianti JP, McFedries A, Foda ZH, Kleiner RE, Du XQ, Leissring MA, Liu, DR (2014). Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones. Nature 511(7507): 94-98. |
|
|
Mamikutty N, Thent ZC, Sapri SR, Sahruddin NN, MohdYusof MR, Haji SF (2014). The establishment of metabolic syndrome model by induction of fructose drinking water in male Wistar rats. Biomed. Res. Int. 2014:263897. |
|
|
Matveyenko AV, Veldhuis JD, Butler PC (2008). Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and β-cell mass to age-related insulin resistance in rats. Am. J. Physiol. Endocrinol. Metab. 295(4):E832-E841. |
|
|
McGarry JD (2001). Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 51(1):7-18. |
|
|
Mittelman SD, Van Citters GW, Kim SP, Davis DA, Dea MK, Hamilton-Wessler M, Bergman RN. (2000). Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced β-cell response. Diabetes 49(12):2116-2125. |
|
|
Moller DE (2001). New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414(6865):821-827. |
|
|
Paschos P, Paletas K (2009). Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia 13(1):9-19. |
|
|
Perna AF, Fadda GZ, Zhou XJ, Massry SG (1990). Mechanisms of impaired insulin secretion after chronic excess of parathyroid hormone. Am. J. Physiol. 259(2 Pt 2):F210-6. |
|
|
Pessin JE, Thurmond DC, Elmendorf JS, Coker KJ, Okada S (1999). Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. J. Biol. Chem. 274(5):2593-2596. |
|
|
Rezende LF, Santos GJ, Santos-Silva JC, Carneiro EM, Boschero AC (2012). Ciliaryneurotrophic factor (CNTF) protects non-obese Swiss mice against type 2 diabetes by increasing β cell mass and reducing insulin clearance. Diabetologia 55(5):1495-504. |
|
|
SlominskiÄ PA, Pivovarova OV, Shadrina MI, Artem'eva AV, Pfaipffer FG, Rudovich NN, Agadzhanian SE, Pronin VS, Limborskaia SA (2009). Association of insulinase gene polymorphisms with type 2 diabetes mellitus in patients from the Moscow population. Genetika 45(1):127-131. |
|
|
Sung CC, Liao MT, Lu KC, Wu CC (2012). Role of vitamin D in insulin resistance. J. Biomed. Biotechnol. 2012. |
|
|
Teegarden D, Donkin SS (2009). Vitamin D: emerging new roles in insulin sensitivity. Nutr. Res. Rev. 22(1):82-92. |
|
|
Wei X, Bilun Ke, Zhiyun Zhao, Xin Ye, Zhanguo Gao, Jianping Ye (2014). Regulation of insulin degrading enzyme activity by obesity-associated factors and pioglitazone in liver of diet-induced obese mice. PLoS One 9(4):e95399. |
|
|
Williams PF, Caterson ID, Cooney GJ, Zilkens RR, Turtle JR (1990). High affinity insulin binding and insulin receptor-effector coupling: modulation by Ca2+. Cell Calcium 11(8):547-556. |
|
|
Yoshii H, Lam TK, Gupta N, Goh T, Haber CA, Uchino H, Kim TT, Chong VZ, Shah K, Fantus IG, Mari A, Kawamori R, Giacca A (2006). Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux. Am. J. Physiol. Endocrinol. Metab. 290(6):E1089-E1097. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
